Hemogenyx Pharmaceuticals PLC Cash Flow Reinvestment Rate
Hemogenyx Pharmaceuticals PLC cash flow reinvestment rate. Hemogenyx Pharmaceuticals PLC (HEMO) has a Cash Flow Reinvestment Rate of 0.47x as of June 2017, reinvesting GBX11.02 (capex GBX11.02 ) from operating cash flow of GBX23.26. Explore Hemogenyx Pharmaceuticals PLC cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Hemogenyx Pharmaceuticals PLC (2015–2015)
Cash flow reinvestment rate of Hemogenyx Pharmaceuticals PLC from 2015 to 2015. Historical reinvestment intensity for Hemogenyx Pharmaceuticals PLC across 1 annual periods. Explore Hemogenyx Pharmaceuticals PLC capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Hemogenyx Pharmaceuticals PLC Cash Flow Reinvestment Rate by Year (2015–2015)
Hemogenyx Pharmaceuticals PLC cash flow reinvestment rate by year from 2015 to 2015. Year-by-year capital reinvestment analysis for Hemogenyx Pharmaceuticals PLC. For the full cash flow conversion analysis, see cash efficiency ratio of Hemogenyx Pharmaceuticals PLC.
| Year | Reinvestment Rate | Total Reinvested (GBX) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2015 | 0.00x | GBX0.00 | GBX79.71 | GBX0.00 | — |